Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Radiation Therapy Oncology Group
National Cancer Institute (NCI)
Children's Oncology Group
Radiation Therapy Oncology Group
Children's Oncology Group
Canadian Cancer Trials Group
Radiation Therapy Oncology Group
Radiation Therapy Oncology Group
Radiation Therapy Oncology Group
Children's Oncology Group
Children's Oncology Group
RTOG Foundation, Inc.
National Cancer Institute (NCI)
GOG Foundation
National Cancer Institute (NCI)